Purdue Pharma to be sentenced in criminal opioids case, allowing for settlement of thousands of lawsuits

The Globe and Mail The Globe and Mail

OxyContin maker agreed in 2020 to forfeit $225-million to resolve federal civil and criminal probes into its role in the opioid crisis

Read full article at The Globe and Mail →